- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 31/04 - Antibacterial agents
Patent holdings for IPC class A61P 31/04
Total number of patents in this class: 14234
10-year publication summary
|
491
|
523
|
879
|
1020
|
1191
|
1312
|
1254
|
1194
|
1323
|
600
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| King Faisal University | 912 |
232 |
| Glaxosmithkline Biologicals S.A. | 1637 |
109 |
| The Regents of the University of California | 19898 |
103 |
| Centre National de La Recherche Scientifique | 10421 |
96 |
| Pfizer Inc. | 3379 |
76 |
| Hoffmann-La Roche Inc. | 3414 |
64 |
| Intervet Inc. | 905 |
64 |
| iNtRON Biotechnology, Inc. | 178 |
61 |
| Intervet International B.V. | 1282 |
58 |
| Wockhardt Limited | 225 |
55 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3369 |
51 |
| Novartis AG | 10847 |
50 |
| Merck Sharp & Dohme LLC | 3750 |
50 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 2812 |
48 |
| President and Fellows of Harvard College | 5975 |
45 |
| Bioversys AG | 69 |
43 |
| Shionogi & Co., Ltd. | 858 |
43 |
| Daiichi Sankyo Company, Limited | 1863 |
41 |
| F. Hoffmann-La Roche AG | 7930 |
40 |
| Rutgers, The State University of New Jersey | 1892 |
39 |
| Other owners | 12866 |